Ninth Circuit judge questions generic drugmakers on imminent harm

Judge Andrew Hurwitz of the US Court of Appeals for the Ninth Circuit has asked generic drugmakers why they need to block a California law restricting pay-for-delay settlements if they do not plan to enter into such agreements.

Unlock unlimited access to all Global Competition Review content